Article
Gene therapy for neuromuscular disorders: prospects and ethics
30 Aug 2021
Abstract excerpt
Most childhood neuromuscular disorders are caused by mutations causing abnormal expression or regulation of single genes or genetic pathways. The potential for gene therapy, gene editing and genetic therapies to ameliorate the course of these conditions is extraordinarily exciting, but there are significant challenges associated with their use, particularly with respect to safety, efficacy, cost and equity....
Topics
Join the communities discussing this publication.